Anemia: Types, Causes, Signs, Symptoms and Pathophysiology

Comprehensive Guide to Anemia: Classifications, Causes, Pathophysiology, and Clinical Manifestations

Anemia is defined as a quantitative reduction in the number of circulating red blood cells (RBCs), hematocrit (Hct), or hemoglobin (Hb) concentration. This reduction compromises the oxygen-carrying capacity of the blood, resulting in tissue hypoxia. For pharmacy and medical students, mastering anemia requires understanding both its morphological categories and the biochemical pathways that govern red cell lifecycle kinetics.

1. Classification of Anemia

Anemia is systematically classified using two distinct frameworks: Morphological (based on red blood cell indices) and Etiological/Pathophysiological (based on the underlying functional defect).

Morphological Classification

This framework relies on the Mean Corpuscular Volume (MCV, indicating cell size) and Mean Corpuscular Hemoglobin Concentration (MCHC, indicating cell color/chromasia).

                 ┌───────────────────────────────┐
                 │    Anemia Diagnosis (Hb ↓)    │
                 └───────────────┬───────────────┘
                                 │
         ┌───────────────────────┼───────────────────────┐
         ▼                       ▼                       ▼
   Microcytic              Normocytic              Macrocytic
  (MCV < 80 fL)          (MCV 80–100 fL)          (MCV > 100 fL)
         │                       │                       │
 ┌───────┴───────┐       ┌───────┴───────┐       ┌───────┴───────┐
 ▼               ▼       ▼               ▼       ▼               ▼
Iron        Thalassemia  Hemolytic     Aplastic Megaloblastic Non-Megaloblastic
Deficiency   (Genetic)   Anemia         Anemia   (B12/Folate)   (Liver Disease)

Pathophysiological / Etiological Classification

This classification focuses on red blood cell kinetics and divides anemia into three primary groups based on production, destruction, or loss:

1. Impaired RBC Production (Hypoproliferative): The bone marrow fails to synthesize sufficient red cells. Examples include aplastic anemia, myelofibrosis, and nutritional deficiencies.

2. Excessive RBC Destruction (Hemolytic): RBC lifespan is reduced below the standard 100–120 days due to intrinsic defects or extrinsic factors.

3. Acute or Chronic Blood Loss (Hemorrhagic): Externalized or internalized bleeding that outpaces bone marrow compensation.

2. Etiology (Causes)

Anemia stems from a broad range of nutritional, genetic, environmental, and pharmacological causes:

• Nutritional Deficiencies: Inadequate dietary intake or malabsorption of iron, vitamin B12, or folic acid. Conditions like celiac disease or surgical interventions like Roux-en-Y gastric bypass heavily impair absorption.

• Blood Loss: Chronic blood loss from gastrointestinal ulcers, malignancies, regular NSAID use, or heavy menstruation. Acute blood loss typically follows major trauma or surgery.

• Immune & Inflammatory Mechanisms: Chronic inflammatory conditions (e.g., rheumatoid arthritis, HIV, inflammatory bowel disease) trigger cytokine releases that disrupt iron utilization. Autoimmune hemolytic anemias involve IgG or IgM antibodies directed against self-erythrocyte antigens.

• Genetic Mutations: Hereditary disorders such as sickle cell anemia (a point mutation substituting valine for glutamic acid at position 6 of the β-globin chain) and thallasemias (imbalanced α or β globin chain synthesis).

• Bone Marrow Suppression: Direct damage to hematopoietic stem cells by toxic chemicals (benzene), radiation, or pharmacological agents like chloramphenicol and chemotherapeutic regimens.

3. Pathophysiology by Major Disease Type

Iron Deficiency Anemia (IDA)

Iron is the central coordination atom in the porphyrin ring of heme. When iron demand exceeds supply, depletion progresses through three distinct stages:

1. Iron Depletion: Storage iron (ferritin) drops, but serum iron and hemoglobin remain stable.

2. Iron-Deficient Erythropoiesis: Serum iron and transferrin saturation drop, leading to an accumulation of free erythrocyte protoporphyrin.

3. Iron Deficiency Anemia: Bone marrow can no longer form functional heme molecules. Erythroid precursors divide repeatedly in an attempt to optimize hemoglobin concentration, producing microcytic, hypochromic red blood cells.

Megaloblastic Anemia (Vitamin B12 & Folate Deficiency)

Vitamin B12 (cobalamin) and folate are necessary coenzymes for the synthesis of deoxythymidine triphosphate (dTTP) from deoxyuridine monophosphate (dUMP). A deficiency in either nutrient impairs DNA synthesis, while RNA synthesis and cytoplasmic growth continue unaffected. This phenomenon, called nuclear-cytoplasmic asynchrony, leaves erythroid precursors with immature nuclei and mature cytoplasm. These large cells undergo intramedullary destruction (ineffective erythropoiesis), and the survivors enter circulation as macrocytes.

Anemia of Chronic Disease / Inflammation (ACD)

During chronic inflammation, cytokines like IL-6 stimulate the liver to overproduce hepcidin, the master regulatory hormone of iron homeostasis. Hepcidin binds to the cellular iron exporter ferroportin on macrophages and enterocytes, inducing its internalization and degradation. This action traps iron inside storage compartments, preventing its release to transferrin and causing a state of functional iron deficiency despite adequate total body iron stores.

Hemolytic Anemia

Hemolytic anemias are characterized by accelerated red cell destruction:

• Extravascular Hemolysis: Defective or antibody-coated RBCs are phagocytosed by macrophages in the spleen and liver. Hemoglobin breakdown generates excess unconjugated bilirubin, which can cause jaundice.

• Intravascular Hemolysis: RBCs lyse directly inside the circulatory system, releasing free hemoglobin into the plasma. This overwhelms the binding capacity of haptoglobin, leading to hemoglobinuria and hemosiderinuria.

4. Signs and Symptoms

The clinical presentation of anemia reflects tissue hypoxia combined with the body's compensatory cardiovascular adjustments.

General Anemic Symptoms (Hypoxia-Driven)

• Fatigue and Lassitude: Diminished oxygen delivery to skeletal muscles impairs aerobic metabolism.

• Dyspnea on Exertion: Respiratory compensation to increase oxygen uptake.

• Skin Pallor: Vasoconstriction of peripheral vascular beds redirects available blood flow toward vital organs.

Compensatory Cardiovascular Signs

• Tachycardia & Palpitations: Sympathetic nervous system activation increases heart rate to maximize cardiac output.

• Flow Murmurs: Reduced blood viscosity combined with high-output cardiac states creates turbulent blood flow across the heart valves.

Etiology-Specific Findings

• Koilonychia (Spoon nails), Glossitis, and Pica: Highly characteristic of advanced iron deficiency anemia.

• Jaundice & Scleral Icterus: Present in hemolytic anemia due to elevated unconjugated bilirubin from rapid red cell breakdown.

• Neurologic Deficits (Subacute Combined Degeneration): Exclusively seen in Vitamin B12 deficiency (pernicious anemia). A lack of cobalamin disrupts methylmalonyl-CoA mutase activity, leading to an accumulation of methylmalonic acid (MMA) that causes progressive demyelination of the spinal cord's posterior and lateral columns.

5. Diagnostic Laboratory Matrix

To differentiate these conditions clinically, providers order a Complete Blood Count (CBC) and interpret a variety of serum biomarkers: